275 related articles for article (PubMed ID: 19837945)
21. Sphingosylphosphorylcholine generates reactive oxygen species through calcium-, protein kinase Cdelta- and phospholipase D-dependent pathways.
Jeon ES; Kang YJ; Song HY; Im DS; Kim HS; Ryu SH; Kim YK; Kim JH
Cell Signal; 2005 Jun; 17(6):777-87. PubMed ID: 15722202
[TBL] [Abstract][Full Text] [Related]
22. Insulin-induced phospholipase D1 and phospholipase D2 activity in human embryonic kidney-293 cells mediated by the phospholipase C gamma and protein kinase C alpha signalling cascade.
Slaaby R; Du G; Altshuller YM; Frohman MA; Seedorf K
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):613-9. PubMed ID: 11042115
[TBL] [Abstract][Full Text] [Related]
23. Temporal production of the signaling lipid phosphatidic acid by phospholipase D2 determines the output of extracellular signal-regulated kinase signaling in cancer cells.
Zhang F; Wang Z; Lu M; Yonekubo Y; Liang X; Zhang Y; Wu P; Zhou Y; Grinstein S; Hancock JF; Du G
Mol Cell Biol; 2014 Jan; 34(1):84-95. PubMed ID: 24164897
[TBL] [Abstract][Full Text] [Related]
24. Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: conditional efficacy of PTH peptide fragments.
Sneddon WB; Magyar CE; Willick GE; Syme CA; Galbiati F; Bisello A; Friedman PA
Endocrinology; 2004 Jun; 145(6):2815-23. PubMed ID: 15016722
[TBL] [Abstract][Full Text] [Related]
25. β-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptor.
van der Lee MM; Verkaar F; Wat JW; van Offenbeek J; Timmerman M; Voorneveld L; van Lith LH; Zaman GJ
Cell Signal; 2013 Feb; 25(2):527-38. PubMed ID: 23159578
[TBL] [Abstract][Full Text] [Related]
26. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.
Yang Y; Wang B
Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699
[TBL] [Abstract][Full Text] [Related]
27. Mutation of phenylalanine-34 of parathyroid hormone disrupts NHERF1 regulation of PTH type I receptor signaling.
Wheeler D; Sneddon WB
Endocrine; 2006 Dec; 30(3):343-52. PubMed ID: 17526947
[TBL] [Abstract][Full Text] [Related]
28. Generation of choline for acetylcholine synthesis by phospholipase D isoforms.
Zhao D; Frohman MA; Blusztajn JK
BMC Neurosci; 2001; 2():16. PubMed ID: 11734063
[TBL] [Abstract][Full Text] [Related]
29. Role of phospholipase D in bleomycin-induced mitochondrial reactive oxygen species generation, mitochondrial DNA damage, and pulmonary fibrosis.
Suryadevara V; Huang L; Kim SJ; Cheresh P; Shaaya M; Bandela M; Fu P; Feghali-Bostwick C; Di Paolo G; Kamp DW; Natarajan V
Am J Physiol Lung Cell Mol Physiol; 2019 Aug; 317(2):L175-L187. PubMed ID: 31090437
[TBL] [Abstract][Full Text] [Related]
30. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells.
Kang DW; Park MH; Lee YJ; Kim HS; Lindsley CW; Alex Brown H; Min do S
Int J Cancer; 2011 Feb; 128(4):805-16. PubMed ID: 20473892
[TBL] [Abstract][Full Text] [Related]
31. Expression of phospholipase D isoforms in mammalian cells.
Meier KE; Gibbs TC; Knoepp SM; Ella KM
Biochim Biophys Acta; 1999 Jul; 1439(2):199-213. PubMed ID: 10425396
[TBL] [Abstract][Full Text] [Related]
32. Differential role for phospholipase D1 and phospholipase D2 in 12-O-tetradecanoyl-13-phorbol acetate-stimulated MAPK activation, Cox-2 and IL-8 expression.
Grab LT; Kearns MW; Morris AJ; Daniel LW
Biochim Biophys Acta; 2004 Feb; 1636(1):29-39. PubMed ID: 14984736
[TBL] [Abstract][Full Text] [Related]
33. Identification of a novel Ca2+-dependent, phosphatidylethanolamine-hydrolyzing phospholipase D in yeast bearing a disruption in PLD1.
Waksman M; Tang X; Eli Y; Gerst JE; Liscovitch M
J Biol Chem; 1997 Jan; 272(1):36-9. PubMed ID: 8995222
[TBL] [Abstract][Full Text] [Related]
34. Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50).
Sneddon WB; Syme CA; Bisello A; Magyar CE; Rochdi MD; Parent JL; Weinman EJ; Abou-Samra AB; Friedman PA
J Biol Chem; 2003 Oct; 278(44):43787-96. PubMed ID: 12920119
[TBL] [Abstract][Full Text] [Related]
35. Dependence of phospholipase D1 multi-monoubiquitination on its enzymatic activity and palmitoylation.
Yin H; Gui Y; Du G; Frohman MA; Zheng XL
J Biol Chem; 2010 Apr; 285(18):13580-8. PubMed ID: 20189990
[TBL] [Abstract][Full Text] [Related]
36. NHERF1 regulates parathyroid hormone receptor desensitization: interference with beta-arrestin binding.
Wang B; Yang Y; Abou-Samra AB; Friedman PA
Mol Pharmacol; 2009 May; 75(5):1189-97. PubMed ID: 19188335
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of mammalian phospholipase D2.
Sung TC; Altshuller YM; Morris AJ; Frohman MA
J Biol Chem; 1999 Jan; 274(1):494-502. PubMed ID: 9867870
[TBL] [Abstract][Full Text] [Related]
38. Phospholipase D1 regulates high-affinity IgE receptor-induced mast cell degranulation.
Hitomi T; Zhang J; Nicoletti LM; Grodzki AC; Jamur MC; Oliver C; Siraganian RP
Blood; 2004 Dec; 104(13):4122-8. PubMed ID: 15339843
[TBL] [Abstract][Full Text] [Related]
39. Hippocalcin increases phospholipase D2 expression through extracellular signal-regulated kinase activation and lysophosphatidic acid potentiates the hippocalcin-induced phospholipase D2 expression.
Oh DY; Yon C; Oh KJ; Lee KS; Han JS
J Cell Biochem; 2006 Apr; 97(5):1052-65. PubMed ID: 16294323
[TBL] [Abstract][Full Text] [Related]
40. Role for phospholipase D in receptor-mediated endocytosis.
Shen Y; Xu L; Foster DA
Mol Cell Biol; 2001 Jan; 21(2):595-602. PubMed ID: 11134345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
